IL‐17 expression was not solely found in T cells in cervical cancers ([37] and this study); however, our analysis revealed that in tumor tissues of patients with lymph node metastases or who retrospectively developed cervical cancer recurrence more CD4+ or IL‐17+ cells represent Th17 cells indicated by higher percentages of Th17 cells per total CD4+ or IL‐17+ cells. The gene discussed is IL17A; the disease is metastatic malignant neoplasm in the lymph nodes.